Determination of polymyxin B in plasma by UPLC-MS/MS and dosage optimization

QIN Yi,YAO Qing-qing,GAO Jie,WANG Yong,HUANG Chen-rong,ZHU Jian-guo,MIAO Li-yan,GUAN Xiao-jun

DOI: https://doi.org/10.13286/j.1001-5213.2023.06.04

2023-01-01

Abstract:OBJECTIVE To develop an ultra-performance liquid chromatography-tandem mass spectrometry（UPLC-MS/MS）method for determination of polymyxin B in plasma.METHODS The analytical column was ACQUITY UPLC HSS T3 column（2.1 mm×100 mm, 1.7 μm）.The mobile phase consisted of aqueous phase A as water and organic phase B composed of methanol and acetonitrile（1∶1,V/V）.Formic acid in all mobile phase was adjusted to 0.2%.The gradient elution lasted 3.5 mins.Electron spray ionization was set at positive mode.Multiple reaction monitoring was performed at m/z 602.4→241.1 for PB1,595.5→100.9 for PB2 and 585.5→202.0 for internal standard PE1.According to one compartment model, trough and peak plasma concentration were obtained to calculate AUC ss, 24h .RESULTS The linear range of PB1 in plasma was 0.05-5 μg·mL -1 and PB2 was 0.015-0.372 μg·mL -1 .The intra-day and inter-day precision were less than 10.9%,and the accuracy was between 88.8% and 105.7%.For the average recoveries was 88.0% to 103.2%,and the matrix effect was 100.0% to 113.7%.The analyte was stable when the plasma samples were stored at room temperature for 6 h, at 4 ℃ for 24 h, after 3 freeze-thaw cycles and-80 ℃ for 30 days.By empirical medication one of six patients included in the observation had an AUC ss, 24h lower than 50 mg·h·L -1 ,which was reported to doctors immediately and after dosage optimization AUC ss, 24h met requirements.CONCLUSION The established UPLC-MS/MS method was rapid, accurate, sensitive and specific and was successfully used to monitor major polymyxin B.The method validation is in according with guidelines for biological samples quantitative analysis.Our method is suitable for polymyxin B therapeutic drug monitoring in clinical practice.